XML 21 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Goodwill
 9 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
A reconciliation of the activity affecting goodwill by operating segment is as follows:
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Balance - March 31, 2024
Goodwill$711,452 $30,384 $741,836 
Accumulated impairment loss(212,516)(1,587)(214,103)
Balance - March 31, 2024498,936 28,797 527,733 
Adjustment related to acquisition— 309 309 
Effects of foreign currency exchange rates— (823)(823)
Balance - December 31, 2024
Goodwill711,452 29,870 741,322 
Accumulated impairment loss(212,516)(1,587)(214,103)
Balance - December 31, 2024$498,936 $28,283 $527,219 
At February 29, 2024, the date of our annual impairment review, the estimated fair value exceeded the carrying value for all reporting units and, accordingly, no impairment charge was taken. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, supply chain constraints, labor shortages, and inflation. The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value. If these assumptions are adversely affected, we may be required to record impairment charges in the future. As of December 31, 2024, we determined no events have occurred that would indicate potential impairment of goodwill.